Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension

NCT02657356 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02657356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Terminated
Start date
October 4, 2016
Completion date
May 7, 2020
Enrollment
202 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disease-associated pulmonary arterial hypertension